Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-1.99M.
ENTERPRISE VALUE (EV)
$-1.99M
Acurx Pharmaceuticals, Inc.
Market Cap
$5.57M
Enterprise Value (EV)
$-1.99M
Market Cap
$5.68M
Enterprise Value (EV)
$3.64M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Acurx Pharmaceuticals, Inc. (ACXP) | $5.57M | $-1.99M |
| Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR)vs › | $5.68M | $3.64M |
| enVVeno Medical Corporation (NVNO)vs › | $5.70M | $3.37M |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | N/A |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.27M | $3.10M |
| Lucyd, Inc (LUCY)vs › | $5.85M | $3.44M |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.21M | $3.64M |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | $3.45M |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.17M | $8.58M |
| Enlivex Therapeutics Ltd. (ENLV)vs › | $5.92M | $17.65M |
Market Cap
$5.57M
Total Debt
$0.00
Cash
$7.56M
Enterprise Value
$-1.99M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
